ID   HepG2 82FR-31NR
AC   CVCL_D5JJ
SY   82FR-31NR; 82 days Fractionated Radiation-31 days Non-Radiation
DR   TKG; TKG 0803
DR   Wikidata; Q127381750
RX   PubMed=23552696;
CC   Population: Caucasian.
CC   Characteristics: Radioresistant. Exposed to X-ray (0.5 Gy) fractionated radiation (FR) for 82 days and cessation of FR for 31 days (PubMed=23552696).
CC   Selected for resistance to: NCIt; C17262; X-Ray.
CC   Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): TKG=TKG 0803
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 13
ST   D16S539: 12,13
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 9
ST   TPOX: 9
ST   vWA: 17
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
RX   PubMed=23552696; DOI=10.1038/oncsis.2012.12; PMCID=PMC3412645;
RA   Shimura T., Noma N., Oikawa T., Ochiai Y., Kakuda S., Kuwahara Y.,
RA   Takai Y., Takahashi A., Fukumoto M.;
RT   "Activation of the AKT/cyclin D1/Cdk4 survival signaling pathway in
RT   radioresistant cancer stem cells.";
RL   Oncogenesis 1:e12.1-e12.9(2012).
//